Literature DB >> 27979896

9. Cardiovascular Disease and Risk Management.

.   

Abstract

Entities:  

Year:  2017        PMID： 27979896     DOI： 10.2337/dc17-S012

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  68 in total

1.  Ideal Cardiovascular Health Metrics and Major Cardiovascular Events in Patients With Prediabetes and Diabetes.

Authors:  Tiange Wang; Jieli Lu; Qing Su; Yuhong Chen; Yufang Bi; Yiming Mu; Lulu Chen; Ruying Hu; Xulei Tang; Xuefeng Yu; Mian Li; Min Xu; Yu Xu; Zhiyun Zhao; Li Yan; Guijun Qin; Qin Wan; Gang Chen; Meng Dai; Di Zhang; Zhengnan Gao; Guixia Wang; Feixia Shen; Zuojie Luo; Yingfen Qin; Li Chen; Yanan Huo; Qiang Li; Zhen Ye; Yinfei Zhang; Chao Liu; Youmin Wang; Shengli Wu; Tao Yang; Huacong Deng; Donghui Li; Shenghan Lai; Zachary T Bloomgarden; Lixin Shi; Guang Ning; Jiajun Zhao; Weiqing Wang
Journal:  JAMA Cardiol       Date:  2019-09-01       Impact factor: 14.676

2.  Increasing SBP variability is associated with an increased risk of developing incident diabetic foot ulcers.

Authors:  Meghan B Brennan; Marylou Guihan; Elly Budiman-Mak; Hyojung Kang; Jennifer M Lobo; Bryn L Sutherland; Nicholas Emanuele; Elbert S Huang; Min-Woong Sohn
Journal:  J Hypertens       Date:  2018-11       Impact factor: 4.844

Review 3.  Pharmacological Prevention of Cardiovascular Outcomes in Diabetes Mellitus: Established and Emerging Agents.

Authors:  David R Saxon; Neda Rasouli; Robert H Eckel
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

4.  Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.

Authors:  Daniel M Rotroff; Sonja S Pijut; Skylar W Marvel; John R Jack; Tammy M Havener; Aurora Pujol; Agatha Schluter; Gregory A Graf; Henry N Ginsberg; Hetal S Shah; He Gao; Mario-Luca Morieri; Alessandro Doria; Josyf C Mychaleckyi; Howard L McLeod; John B Buse; Michael J Wagner; Alison A Motsinger-Reif
Journal:  Clin Pharmacol Ther       Date:  2017-11-03       Impact factor: 6.875

Review 5.  Blood pressure management in patients with type 2 diabetes mellitus.

Authors:  Hisashi Kai
Journal:  Hypertens Res       Date:  2017-04-27       Impact factor: 3.872

6.  Smoking cessation and weight change in relation to cardiovascular disease incidence and mortality in people with type 2 diabetes: a population-based cohort study.

Authors:  Gang Liu; Yang Hu; Geng Zong; An Pan; JoAnn E Manson; Kathryn M Rexrode; Eric B Rimm; Frank B Hu; Qi Sun
Journal:  Lancet Diabetes Endocrinol       Date:  2020-01-07       Impact factor: 32.069

7.  ADDRESSING HYPERTENSION IN THE PATIENT WITH TYPE 2 DIABETES MELLITUS: PATHOGENESIS, GOALS, AND THERAPEUTIC APPROACH.

Authors:  Ali A Rizvi
Journal:  Eur Med J Diabetes       Date:  2017-10

Review 8.  The shifting paradigm in the treatment of type 2 diabetes mellitus-A cardiologist's perspective.

Authors:  Saeeda Fatima; Ayesha Jameel; Fnu Ayesha; Dhananjai J Menzies
Journal:  Clin Cardiol       Date:  2017-08-25       Impact factor: 2.882

9.  Lowering low-density lipoprotein cholesterol by PCSK9 inhibition in patients with diabetes on insulin therapy: is it efficacious and safe?

Authors:  Michel Farnier
Journal:  Ann Transl Med       Date:  2018-02

10.  Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacy practice.

Authors:  Amir Sarayani; Mojgan Mashayekhi; Marzieh Nosrati; Zahra Jahangard-Rafsanjani; Mohammadreza Javadi; Navid Saadat; Sheyda Najafi; Kheirollah Gholami
Journal:  Int J Clin Pharm       Date:  2018-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.